{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:01:50Z","timestamp":1790996510219,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100000589","name":"Chief Scientist Office","doi-asserted-by":"publisher","award":["Applied Research Programme Grant ARPG\/07\/1"],"award-info":[{"award-number":["Applied Research Programme Grant ARPG\/07\/1"]}],"id":[{"id":"10.13039\/501100000589","id-type":"DOI","asserted-by":"publisher"}]},{"name":"RS MacDonald Trust"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12883-017-0904-4","type":"journal-article","created":{"date-parts":[[2017,6,30]],"date-time":"2017-06-30T21:52:14Z","timestamp":1498859534000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":95,"title":["Co-morbidity and polypharmacy in Parkinson\u2019s disease: insights from a large Scottish primary care database"],"prefix":"10.1186","volume":"17","author":[{"given":"Gary","family":"McLean","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John V.","family":"Hindle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Guthrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stewart W.","family":"Mercer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,1]]},"reference":[{"key":"904_CR1","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/S0140-6736(09)60492-X","volume":"373","author":"AJ Lees","year":"2009","unstructured":"Lees AJ, Hardy J, Revesz T. Parkinson's disease. Lancet. 2009;373:2055\u201366.","journal-title":"Lancet"},{"key":"904_CR2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1136\/jnnp.62.1.10","volume":"62","author":"MC Rijk De","year":"1997","unstructured":"De Rijk MC, Tzourio C, Breteler MMB, Dartigues JF, Amaducci L, Lopez-Pousa S, et al. for the EUROPARKINSON Study Group. Prevalence of Parkinsonism and Parkinson\u2019s disease in Europe: the EUROPARKINSON collaborative study. J Neurol Neurosurg Psychiatry. 1997;62:10\u20135.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"904_CR3","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.euroneuro.2005.04.007","volume":"15","author":"S Campenhausen von","year":"2005","unstructured":"von Campenhausen S, Bornschein B, Wick R, B\u00f6tzel K, Sampaio C, Poewe W, et al. Prevalence and incidence of Parkinson's disease in Europe. Eur Neuropsychopharmacol. 2005;15:473\u201390.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"6","key":"904_CR4","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","volume":"5","author":"LM Lau de","year":"2006","unstructured":"de Lau LM, Breteler MM. Epidemiology of Parkinson's disease. Lancet Neurol. 2006;5(6):525\u201335.","journal-title":"Lancet Neurol"},{"key":"904_CR5","unstructured":"Parkinson\u2019s UK. Parkinson\u2019s prevalence in the United Kingdom. 2009. \nhttps:\/\/www.parkinsons.org.uk\/sites\/default\/files\/parkinsonsprevalenceuk_0.pdf\n\n."},{"key":"904_CR6","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1212\/01.wnl.0000247740.47667.03","volume":"68","author":"ER Dorsey","year":"2007","unstructured":"Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K, et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology. 2007;68:384\u20136.","journal-title":"Neurology"},{"issue":"Suppl. S1","key":"904_CR7","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1002\/mds.22786","volume":"25","author":"SY Lim","year":"2010","unstructured":"Lim SY, Lang AE. The Nonmotor Symptoms of Parkinson\u2019s Disease\u2014An Overview. Mov Disord. 2010;25(Suppl. S1):S123\u201330.","journal-title":"Mov Disord"},{"issue":"3","key":"904_CR8","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1017\/S0033291715002196","volume":"46","author":"S Landau","year":"2016","unstructured":"Landau S, Harris V, Burn DJ. Anxiety and anxious-depression in Parkinson's disease over a 4-year period: a latent transition analysis. Psychol Med. 2016;46(3):657\u201367.","journal-title":"Psychol Med"},{"key":"904_CR9","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1007\/s00415-012-6557-8","volume":"259","author":"A Antonini","year":"2012","unstructured":"Antonini A, Barone P, Marconi R, Morgante L, Zappulla S, Pontieri FE, et al. The progression of non-motor symptoms in Parkinson\u2019s disease and their contribution to motor disability and quality of life. J Neurol. 2012;259:2621\u201331.","journal-title":"J Neurol"},{"key":"904_CR10","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/ageing\/afs161","volume":"42","author":"F Bos van den","year":"2013","unstructured":"van den Bos F, Speelman AD, Samson M, Munneke M, Bloem BR, Verhaar HJ. Parkinson\u2019s disease and osteoporosis. Age Ageing. 2013;42:156\u201362.","journal-title":"Age Ageing"},{"key":"904_CR11","doi-asserted-by":"crossref","first-page":"h176","DOI":"10.1136\/bmj.h176","volume":"350","author":"E Wallace","year":"2015","unstructured":"Wallace E, Salisbury C, Guthrie B, Lewis C, Fahey T, Smith SM. Managing patients with multimorbidity in primary care. BMJ. 2015;350:h176.","journal-title":"BMJ"},{"key":"904_CR12","doi-asserted-by":"crossref","first-page":"e003610","DOI":"10.1136\/bmjopen-2013-003610","volume":"3","author":"C Sinnott","year":"2013","unstructured":"Sinnott C, Mc Hugh S, Browne J, Bradley C. GPs\u2019 perspectives on the management of patients with multimorbidity: systematic review and synthesis of qualitative research. BMJ Open. 2013;3:e003610.","journal-title":"BMJ Open"},{"key":"904_CR13","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1056\/NEJMsb042458","volume":"351","author":"ME Tinetti","year":"2004","unstructured":"Tinetti ME, Bogardus ST Jr, Agostini JV. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N Engl J Med. 2004;351:2870\u20134.","journal-title":"N Engl J Med"},{"key":"904_CR14","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1212\/01.wnl.0000268695.63392.10","volume":"69","author":"B Ravina","year":"2007","unstructured":"Ravina B, Camicioli R, Como PG, Marsh L, Jankovic J, Weintraub D, et al. The impact of depressive symptoms in early Parkinson disease. Neurology. 2007;69:342\u20137.","journal-title":"Neurology"},{"issue":"3","key":"904_CR15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1525-8610(04)70110-3","volume":"5","author":"GA Kang","year":"2004","unstructured":"Kang GA, Bronstein JM. Psychosis in nursing home patients with Parkinson's disease. J Am Med Dir Assoc. 2004;5(3):167\u201373.","journal-title":"J Am Med Dir Assoc"},{"issue":"11","key":"904_CR16","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.apmr.2014.07.396","volume":"95","author":"LA King","year":"2014","unstructured":"King LA, Priest KC, Nutt J, Chen Y, Chen Z, Melnick M, et al. Comorbidity and Functional Mobility in Persons with Parkinson Disease. Arch Phys Med Rehabil. 2014;95(11):2152\u20137.","journal-title":"Arch Phys Med Rehabil"},{"key":"904_CR17","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/mds.20685","volume":"21","author":"CL Leibson","year":"2006","unstructured":"Leibson CL, Maraganore DM, Bower JH. Comorbid conditions associated with Parkinson's disease: a population-based study. Mov Disord. 2006;21:446\u201355.","journal-title":"Mov Disord"},{"key":"904_CR18","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.jclinepi.2006.01.005","volume":"59","author":"J Nuyen","year":"2006","unstructured":"Nuyen J, Schellevisa FG, Satarianob WA, Spreeuwenberg PM, Birkner MD, van den Bos GA, et al. Comorbidity was associated with neurologic and psychiatric diseases: a general practice-based controlled study. J Clin Epidemiol. 2006;59:1274\u201384.","journal-title":"J Clin Epidemiol"},{"key":"904_CR19","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1479-8301.2011.00369.x","volume":"11","author":"SW Lai","year":"2011","unstructured":"Lai SW, Su LT, Lin CH, Tsai CH, Sung FC, Hsieh DP. Polypharmacy increases the risk of Parkinson's disease in older people in Taiwan: a population-based study. Psychogeriatrics. 2011;11:150\u20136.","journal-title":"Psychogeriatrics"},{"key":"904_CR20","volume-title":"Edinburgh: Information and Statistics Division: NHS National Services Scotland","author":"R Elder","year":"2007","unstructured":"Elder R, Kirkpatrick M, Ramsay W. Measuring quality in primary medical services using data from SPICE. In:  Edinburgh: Information and Statistics Division: NHS National Services Scotland; 2007."},{"issue":"9836","key":"904_CR21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0140-6736(12)60240-2","volume":"380","author":"K Barnett","year":"2012","unstructured":"Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380(9836):37\u201343.","journal-title":"Lancet"},{"key":"904_CR22","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/1741-7015-11-263","volume":"11","author":"DJ Smith","year":"2013","unstructured":"Smith DJ, Martin DJ, McLean G, Langan J, Guthrie B, Mercer SW. Multimorbidity in bipolar disorder and under treatment of cardiovascular disease: cross sectional study. BMC Med. 2013;11:263\u201374.","journal-title":"BMC Med"},{"key":"904_CR23","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s12916-014-0181-7","volume":"12","author":"H Court","year":"2014","unstructured":"Court H, McLean G, Guthrie B, Mercer SW, Smith DJ. Visual impairment is associated with physical and mental comorbidities in older adults: a cross-sectional study. BMC Med. 2014;12:181.","journal-title":"BMC Med"},{"key":"904_CR24","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12875-015-0329-3","volume":"16","author":"SA Cooper","year":"2015","unstructured":"Cooper SA, McLean G, Guthrie B, McConnachie A, Mercer S, Sullivan F, et al. Multiple physical and mental health comorbidity in adults with intellectual disabilities: population-based cross-sectional analysis. BMC Fam Pract. 2015;16:110.","journal-title":"BMC Fam Pract"},{"key":"904_CR25","doi-asserted-by":"crossref","first-page":"vII18","DOI":"10.1007\/s00415-004-1706-3","volume":"251","author":"A Ueki","year":"2004","unstructured":"Ueki A, Otsuka M. Life style risks of Parkinson's disease: Association between decreased water intake and constipation. J Neurol. 2004;251:vII18\u201323.","journal-title":"J Neurol"},{"issue":"3","key":"904_CR26","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF00687767","volume":"76","author":"K Wakabayashi","year":"1988","unstructured":"Wakabayashi K, Takahashi H, Takeda S, Ohama E, Ikuta F. Parkinson's disease: the presence of Lewy bodies in Auerbach's and Meissner's plexuses. Acta Neuropathol (Berl). 1988;76(3):217\u201321.","journal-title":"Acta Neuropathol (Berl)"},{"issue":"11","key":"904_CR27","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1093\/brain\/aww175","volume":"139","author":"RS Weil","year":"2016","unstructured":"Weil RS, Schrag AE, Warren JD, Crutch SJ, Lees AJ, Morris HR. Visual dysfunction in Parkinson\u2019s disease. Brain. 2016;139(11):2827\u201343.","journal-title":"Brain"},{"key":"904_CR28","doi-asserted-by":"crossref","unstructured":"Malek N, Lawton MA, \nSwallow DM\n\n. Vascular disease and vascular risk factors in relation to motor features and cognition in early Parkinson's disease. Mov Disord. 2016;31:1518\u201326.","DOI":"10.1002\/mds.26698"},{"issue":"1","key":"904_CR29","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00415-013-7135-4","volume":"261","author":"D Guidez","year":"2014","unstructured":"Guidez D, Behnke S, Halmer R, Dillmann U, Fa\u00dfbender K, Kirsch CM, et al. Is reduced myocardial sympathetic innervation associated with clinical symptoms of autonomic impairment inidiopathic Parkinson's disease? J Neurol. 2014;261(1):45\u201351.","journal-title":"J Neurol"},{"issue":"9","key":"904_CR30","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/S1474-4422(16)30079-5","volume":"15","author":"AJ Espay","year":"2016","unstructured":"Espay AJ, LeWitt PA, Hauser RA. Neurogenic orthostatic hypotension and supine hypertension in Parkinson's disease and related synucleinopathies: prioritisation of treatment targets. Lancet Neurol. 2016;15(9):954\u201366.","journal-title":"Lancet Neurol"},{"key":"904_CR31","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00401-010-0718-6","volume":"120","author":"C Iadecola","year":"2010","unstructured":"Iadecola C. The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia. Acta Neuropathol. 2010;120:287\u201396.","journal-title":"Acta Neuropathol"},{"issue":"3","key":"904_CR32","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1017\/S0033291715002196","volume":"46","author":"S Landau","year":"2016","unstructured":"Landau S, Harris V, Burn DJ, Hindle JV, Hurt CS, et al. Anxiety and anxious-depression in Parkinson's disease over a 4-year period: a latent transition analysis. Psychol Med. 2016;46(3):657\u201367.","journal-title":"Psychol Med"},{"issue":"12","key":"904_CR33","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1002\/mds.26431","volume":"30","author":"D Berg","year":"2015","unstructured":"Berg D, Postuma RB, Adler CH, Bloem BR, Chan P, Dubois B, et al. MDS research criteria for prodromal Parkinson's disease. Mov Disord. 2015;30(12):1600\u201311.","journal-title":"Mov Disord"},{"issue":"6","key":"904_CR34","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/mds.21956","volume":"23","author":"MA Hely","year":"2008","unstructured":"Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG. The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Mov Disord. 2008;23(6):837\u201344.","journal-title":"Mov Disord"},{"issue":"2","key":"904_CR35","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/ageing\/afp223","volume":"39","author":"JV Hindle","year":"2010","unstructured":"Hindle JV. Ageing, neurodegeneration and Parkinson's disease. Age Ageing. 2010;39(2):156\u201361.","journal-title":"Age Ageing"},{"issue":"10","key":"904_CR36","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.parkreldis.2012.09.004","volume":"18","author":"DJ Daley","year":"2012","unstructured":"Daley DJ, Myint PK, Gray RJ, Deane KHO. Systematic review on factors associated with medication non-adherence in Parkinson\u2019s disease. Parkinsonism Relat Disord. 2012;18(10):1053\u201361.","journal-title":"Parkinsonism Relat Disord"},{"key":"904_CR37","doi-asserted-by":"crossref","unstructured":"Hughes TA, Ross HF, Mindham RHS, \nSpokes EG\n\n. Mortality in Parkinson's disease and its association with dementia and depression. Acta Neurol Scand. 2004;110(2):118\u2013123.","DOI":"10.1111\/j.1600-0404.2004.00292.x"},{"issue":"7","key":"904_CR38","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/mds.21504","volume":"22","author":"JV Hindle","year":"2007","unstructured":"Hindle JV, Hindle CM, Hobson P. Co-morbidity and the frequency of general practitioner consultations in Parkinson's disease in the United Kingdom. Mov Disord. 2007;22(7):1054\u20136.","journal-title":"Mov Disord"},{"key":"904_CR39","volume-title":"National Institute for Health and Care Excellence, London, UK","author":"National Institute for Health and Care Excellence","year":"2017","unstructured":"National Institute for Health and Care Excellence. Multimorbidity: clinical assessment and management. In press September. In:  National Institute for Health and Care Excellence, London, UK; 2017."}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-017-0904-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,30]],"date-time":"2017-06-30T21:52:41Z","timestamp":1498859561000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-017-0904-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["904"],"URL":"https:\/\/doi.org\/10.1186\/s12883-017-0904-4","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,1]]},"article-number":"126"}}